A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
Clinical trial NCT05018585 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05018585
- Sponsor
- Diamyd Medical AB
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-19
- Primary completion
- 2027-12-01
- Enrollment
- 321
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.